Mutant Alanine Position

Slides:



Advertisements
Similar presentations
P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.
Advertisements

Supplemental Figure 1 A. EpCAM Gating Strategy Top Row: Histogram showing unstained BT474 cells with low fluorescent intensity of the EpCAM specific PE.
KS + Ima + Zvad % of positive cells (ANV+) Cells positive for SA-β-gal (%) Cells positive for SA-β-gal (%) % of positive cells (ANV+) Supplementary Figure.
A B C D Rao et al., 2012; Supplementary Figure S1 p = 0.03 p = NS
Molecular Therapy - Oncolytics
Compound IC50 [nM] α5β1 αvβ3 References (ref.; Compound name) 1 2,3
Supplemental Figure 1 Supplemental Figure 1: IL-10 production in positively or negatively selected B cells. B cells were isolated with un-touched (Untouched.
Wiskott-Aldrich Syndrome/X-Linked Thrombocytopenia: WASP Gene Mutations, Protein Expression, and Phenotype by Qili Zhu, Chiaki Watanabe, Ting Liu, Diane.
Fig. 1. Generation of ERY974. Generation of ERY974. (A) Schematic illustration of ERY974 structure and the introduced mutations. The two Fab arms share.
CD6 Ligation Modulates the Bcl-2/Bax Ratio and Protects Chronic Lymphocytic Leukemia B Cells From Apoptosis Induced by Anti-IgM by Lyda M. Osorio, Angelina.
CD4+ICOS+IL-4+ TFH cells are sparse in human SLOs.
Figure 2 GlyR antibody binding
Essential role of the C5a receptor in E coli–induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.
Cytokine and chemokine expression of flucloxacillin-specific T cell clones (TCC) of patient P1. Cytokine and chemokine expression of flucloxacillin-specific.
Figure 1 CAR-T-cell design
Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA by Caterina Milazzo, Volker L. Reichardt, Martin.
Figure 3 Antibodies to MOG using different secondary antibodies: Anti-human IgG (H + L), IgG1, or IgM(A) Comparison of binding to full-length myelin oligodendrocyte.
by Éric Aubin, Réal Lemieux, and Renée Bazin
IL-21 induces the expression of CX3CL1 in the muscle in EAM
Comparative analysis of RNA and protein profiles.
SDC 2 - Figure S1.
Volume 8, Issue 6, Pages (June 1998)
the common cytokine receptor g chain,
Supplemental Tables/Figures
SP1 was a downstream target of miR-150-3p
Figure DPPX antibodies as detected by fluorescence-based immunohistochemistry and a cell-based assayImmunohistochemistry displayed binding of the patient's.
Correlation between disease activity and phospho-H2AX levels at G0/G1, S and G2 cell-cycle phases in primary CD3+ T cells and monocytes from patients with.
Cetuximab treatment increases IFNγ receptor 1 expression.
Sequencing at 10,000x using Illumina paired reads
Volume 25, Issue 8, Pages (August 2017)
Volume 12, Issue 15, Pages (August 2002)
a c b d e * * - + Supplementary Figure 0.2 HCF (ALP / G3PDH) 0.1 SK-1
Colonization with N. musculi results in Ab production.
Loss of pathogen-specific T cell memory is due to the absence of Runx2 in CD8+ T cells. Loss of pathogen-specific T cell memory is due to the absence of.
Fig. 6. Safety assessment in cynomolgus monkey.
Volume 8, Issue 3, Pages (March 1998)
Roth et al, Supplementary Figure 1
Core 2 O-glycan synthesis is stimulated by IL-15 signaling.
The landscape of cytokine-producing CD4 T cell populations in the peripheral blood (PB) and in the joints. Venn diagrams show the frequency of overlapping.
Figure S4 control-siRNA Day 0 fes A-siRNA Day 3 fer 1-siRNA
(A) Phospho-H2AX levels are significantly increased in CD4+ T cells, CD8+ T cells and monocytes from SLE compared with those from healthy controls (p=2.16×10−4,
T exosomes bind MAdCAM-1 via RA-increased integrin α4β7.
TLR9 deficiency promotes aberrant T cell and myeloid dendritic cell (DC) phenotype in imiquimod-induced autoimmunity. TLR9 deficiency promotes aberrant.
CD44 binding surface of the Tiam2 PHCCEx domain.
Binding competition between B2′B3 and B3 fragments of TcdB.
Figure 1 Distribution of MOG IgG antibody in pediatric demyelinating diseases Distribution of MOG IgG antibody in pediatric demyelinating diseases (A)
Silva H Hanissian, Raif S Geha  Immunity 
Figure 3 DMF promotes an anti-inflammatory cytokine B-cell profile
IRF4 expression regulates the sensitivity of CD8+ T cells to IL-2, IL-15, and IL-7. IRF4 expression regulates the sensitivity of CD8+ T cells to IL-2,
Phillip D. Holler, David M. Kranz  Immunity 
WASP deficiency produces aberrant F-actin distribution, increased adhesion and downregulation of CD43 during megakaryocytic differentiation. WASP deficiency.
Volume 20, Issue 3, Pages (March 2013)
Figure 2 Cell-based assay demonstrating differential binding of AChR antibodies to the adult and fetal receptorsThe fetal (gamma subunit specific) and.
Phenotypic characterization of splenic and islet-infiltrating B-cells in 12-week-old NOD female mice. Phenotypic characterization of splenic and islet-infiltrating.
Comparison of A2-CMVpp65495–503 and A2-PPI15–24 CD8 T-cell clones killing of cognate peptide-pulsed targets and granule content. Comparison of A2-CMVpp65495–503.
Assessing the effect of TNF-α and TRAIL on A2-PPI15–24 CD8 T-cell cytotoxicity. Assessing the effect of TNF-α and TRAIL on A2-PPI15–24 CD8 T-cell cytotoxicity.
Characteristics of GM-CSF–secreting CD4+ T cells.
Molecular Therapy - Oncolytics
Natural processing and presentation of the HOM-MEL-40/SSX2-derived p peptide. Natural processing and presentation of the HOM-MEL-40/SSX2-derived.
Evaluation of top candidate clones for selective killing in bispecific antibody format. Evaluation of top candidate clones for selective killing in bispecific.
Volume 22, Issue 1, Pages (January 2015)
Binding and internalization of bispecific immunotoxins.
PBMC- and T cell-dependent cytotoxic activity of DCH and variant proteins. PBMC- and T cell-dependent cytotoxic activity of DCH and variant proteins. A.
HLA-A*0201 restriction of SSX2-derived p stimulated CD8+ T-cells.
Confocal microscopy analysis of SK-BR-3 and HC cells treated with CF488A-labeled HER2-lytic hybrid peptide. Confocal microscopy analysis of SK-BR-3 and.
Dysregulated NF-κB activation in Il1r8+/+/lpr and Il1r8−/−/lpr mice.
Effect of nivolumab or ipilimumab on immune responses to vaccination in cynomolgus monkeys. Effect of nivolumab or ipilimumab on immune responses to vaccination.
Aptamers for CD Antigens: From Cell Profiling to Activity Modulation
TLR9 deficiency leads to more severe impairment of endothelium-dependent vasorelaxation and promotes aberrant B cell phenotype in imiquimod-induced autoimmunity.
**** *** * **** **** *** Shahriary et al.- Supplementary Figure 4 (a)
Presentation transcript:

Mutant Alanine Position Supplementary Figure 1 Liu et al. A Clone A Clone B Clone C Clone D Events MFI MFI MFI MFI T2-AFP158 T2-AFP158 Ala-1 T2-AFP158 Ala-3 T2-AFP158 Ala-4 T2-AFP158 Ala-5 T2-AFP158 Ala-6 T2-AFP158 Ala-7 T2-AFP158 Ala-8 B Alanine scanning results: mean fluorescence intensity (MFI) Peptide Mutant Alanine Position Clone A Clone B Clone C Clone D FMNKFIYEI   37900 30400 14400 30100 AMNKFIYEI 1 468 12300 5458 21000 FMAKFIYEI 3 4470 38600 38200 786 FMNAFIYEI 4 21 15 38 79 FMNKAIYEI 5 21800 3719 49300 34 FMNKFAYEI 6 18800 169 40300 28 FMNKFIAEI 7 42500 1110 29300 907 FMNKFIYAI 8 38500 1748 53300 16100

Supplementary Figure 2 Liu et al.

Supplementary Figure 3 Liu et al. A B

Supplementary Figure 4 Liu et al. A B IL-6 IL-4 IL-8 GM-CSF IL-10 CD4 SK- HEP-1-MG SK-HEP-1 Hep G2 A IL-4 IL-8 GM-CSF IL-10 Hep G2 B CD4 T Cells Only SK-HEP-1 (A2+/AFP-) SK-HEP-1-MG (A2+/AFP+) Hep G2 (A2+/AFP+) 19.5 45.0 19.6 36.3 18.1 17.4 30.5 18.2 18.6 25.5 1.1 8.1 9.5 41.6 59.0 31.0 7.1 5.1 1.3 31.4 56.2 37.4 0.2 0.0 0.1 59.3 40.5 61.2 38.7 38.8 61.0 30.7 61.1 37.9 61.6 40.2 59.6 41.5 58.3 58.6 43.7 56.3 43.9 55.9 TNFα IFNɣ IL-2 IL-6

Supplementary Figure 5 Liu et al. Hep G2 (A2+/AFP+) SK-HEP-1 (A2+/AFP-) SK-HEP-1-MG (A2+/AFP+) Phase contrast PI

E:T=5:1 Supplementary Figure 6 Liu et al. A B C Mock AFP-CAR Mock AFP- Unstained Mock AFP- CAR C E:T=5:1 Mock AFP-CAR Hep G2 SK-HEP-1 SK-HEP-1-MG

Supplementary Figure 7 Liu et al. AFP-CAR Mock CAR+ CD4+ CAR- CD4+

a′ a b′ c′ b c α-human CD3 α-human CD3 Supplementary Figure 8 Liu et al. A α-human CD3 a′ a b′ c′ b c B α-human CD3

Supplementary Figure 9 Liu et al. A B

Chimeric mouse IgG1 antibody binding affinity to AFP158/HLA-A*02:01 Supplementary Table 1 Liu et al. Chimeric mouse IgG1 antibody binding affinity to AFP158/HLA-A*02:01 Clone # ka [1/Ms] kd [1/s] KD [nM] A 1.17E+06 2.35E-04 0.201 B 5.13E+05 1.31E-05 0.0255 C 6.32E+05 1.10E-04 0.173 D 4.60E+05 5.33E-05 0.116